L'IMPERIO, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 4.676
EU - Europa 3.110
AS - Asia 853
SA - Sud America 11
AF - Africa 10
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.669
Nazione #
US - Stati Uniti d'America 4.612
IT - Italia 1.129
DE - Germania 539
IE - Irlanda 456
SE - Svezia 380
CN - Cina 352
HK - Hong Kong 199
SG - Singapore 126
RU - Federazione Russa 114
GB - Regno Unito 92
AT - Austria 78
UA - Ucraina 68
FI - Finlandia 60
VN - Vietnam 58
FR - Francia 56
DK - Danimarca 55
CA - Canada 50
ID - Indonesia 34
IN - India 29
NL - Olanda 20
BE - Belgio 14
MX - Messico 14
TR - Turchia 14
CH - Svizzera 11
GR - Grecia 10
JP - Giappone 10
KR - Corea 10
PT - Portogallo 8
CZ - Repubblica Ceca 7
AU - Australia 5
BR - Brasile 5
PK - Pakistan 5
ES - Italia 4
RS - Serbia 4
TH - Thailandia 4
CO - Colombia 3
IR - Iran 3
PE - Perù 3
SC - Seychelles 3
BG - Bulgaria 2
EU - Europa 2
MU - Mauritius 2
SA - Arabia Saudita 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
BT - Bhutan 1
DZ - Algeria 1
EG - Egitto 1
HU - Ungheria 1
IL - Israele 1
KZ - Kazakistan 1
MA - Marocco 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RO - Romania 1
ZA - Sudafrica 1
Totale 8.669
Città #
Ann Arbor 1.476
Dublin 440
Frankfurt am Main 440
Fairfield 384
Chandler 346
Milan 298
Wilmington 284
Ashburn 280
Woodbridge 219
New York 215
Hong Kong 199
Houston 198
Seattle 143
Princeton 131
Dearborn 128
Cambridge 114
Shanghai 85
Singapore 78
Jacksonville 76
Vienna 75
Dong Ket 54
Nanjing 54
Altamura 52
Lawrence 50
Helsinki 38
Jakarta 34
Lissone 29
Beijing 28
Boardman 24
London 24
Guangzhou 23
Nanchang 23
San Diego 23
Rome 22
Toronto 19
Falls Church 18
Andover 16
Los Angeles 16
Monza 16
Bologna 14
Hebei 14
Shenyang 14
Jinan 13
Naples 13
Pune 13
Cilavegna 12
Genoa 12
Brescia 11
Brussels 11
Centro Municipality 11
Florence 11
Lappeenranta 11
Caronno Pertusella 10
Ottawa 10
San Mateo 10
Tianjin 10
Turin 10
Cinisello Balsamo 9
Desio 9
Fremont 9
Hangzhou 9
Lachine 9
Assago 8
Bonndorf 8
Carate Brianza 8
Kunming 8
Norwalk 8
Terni 8
Jiaxing 7
Palermo 7
Paullo 7
Sacramento 7
Sesto San Giovanni 7
Zhengzhou 7
Edmonton 6
Ningbo 6
Santa Clara 6
Saronno 6
Taizhou 6
Vrilissia 6
Bari 5
Changsha 5
Chicago 5
Daejeon 5
Höri 5
Kiev 5
Kocaeli 5
Napoli 5
San Giuliano Milanese 5
Tokyo 5
Athens 4
Bangkok 4
Belgrade 4
Frederiksberg 4
Gessate 4
Gorgonzola 4
Groningen 4
Hyderabad 4
Lamezia Terme 4
Levate 4
Totale 6.643
Nome #
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 300
MALDI imaging in Fabry nephropathy: a multicenter study 290
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 253
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 250
The proteomic landscape of renal tumors 237
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 221
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 221
Analysis of Hashimoto's thyroiditis on fine needle aspiration samples by MALDI-Imaging 216
The putative role of MALDI-MSI in the study of Membranous Nephropathy 212
Kidney Involvement 211
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 209
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 208
Proteomics for the study of new biomarkers in Fabry disease: State of the art 196
Proteome analysis in thyroid pathology 181
Cytopathology of Bronchoalveolar Lavages in COVID-19 Pneumonia: A Pilot Study 177
Nodal monoclonal CD5-positive B-lymphocytosis and toxoplasma lymphadenitis: Another variant in the spectrum of infectious lymphadenitis in patients with chronic leukemia/small lymphocytic lymphoma 174
Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis 170
Granulomatosis with polyangiitis presenting with diffuse alveolar hemorrhage requiring extracorporeal membrane oxygenation with rapid multiorgan relapse: A case report 170
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 159
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 149
PD-L1 Testing and Squamous Cell Carcinoma of the Head and Neck: A Multicenter Study on the Diagnostic Reproducibility of Different Protocols 148
Immunosuppression in idiopathic membranous nephropathy: A double-edge sword 145
Displaced Cartilage Within Lymph Node Parenchyma Is a Novel Biopsy Site Change in Resected Mediastinal Lymph Nodes Following EBUS-TBNA 138
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 128
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 127
Monoclonal gammopathy of renal significance: Systemic involvement by benign condition 123
Anticoagulant-related nephropathy: a pathological note 123
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 120
Diagnostic performances of the acr-tirads system in thyroid nodules triage: A prospective single center study 119
Cytomolecular Classification of Thyroid Nodules Using Fine-Needle Washes Aspiration Biopsies 118
More than an ‘atypical’ phenotype: dual molecular diagnosis of autoimmune lymphoproliferative syndrome and Becker muscular dystrophy 114
MALDI-MS imaging in the study of glomerulonephritis 113
#EBUSTwitter: Novel use of social media for conception, coordination, and completion of an international, multicenter pathology study 111
Liquid-based shaking of core needle biopsy samples for the molecular characterization of tumors: A fallback in cytopathology 111
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 110
Autopsia di Innocenzo XII. Un’attestazione dell’utilizzo del microscopio in ambito necroscopico nel XVII secolo 106
Destructuring glomerular diseases with structured deposits: challenges in the precision medicine era 104
The putative role of MALDI-MSI in the study of Membranous Nephropathy 103
The putative role of MALDI-MSI in the study of Membranous Nephropathy 98
Response to: 'Correspondence on 'Bowman's capsule rupture on renal biopsy improves the outcome prediction of ANCA-associated glomerulonephritis classifications'' by Hakroush and Tampe 89
Tumour incidence in Fabry disease: A cross-sectional study 87
Kidney Function, CKD Causes, and Histological Classification 84
Improvements in digital pathology equipment for renal biopsies: updating the standard model 81
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 77
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs) 75
The role of digital and integrative pathology for the detection of translocations: a narrative review 73
MALDI-MS Imaging Application in Thyroid FNA: Challenges and Perspectives 72
Dissecting the histological features of lupus nephritis highlights new common patterns of injury in class III/IV 71
Imaging molecolare a livello cellulare: possiamo predire la risposta alla terapia nella Nefropatia Membranosa? 70
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 70
MALDI-MS Imaging in Membranous Nephropathy: from the research to the clinical laboratory? 69
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 67
The spectrum of the cytopathological features of primary effusion lymphoma and human herpes virus 8-related lymphoproliferative disorders 66
High spatial resolution MALDI-MSI in the search for proteomic indicators of response to therapy in Membranous Nephropathy 65
MALDI-MS imaging in the search for proteomic indicators of response to therapy in membranous nephropathy 59
JAK2-mutated Langerhans cell histiocytosis associated with primary myelofibrosis treated with ruxolitinib 58
Unveiling the Role of Additional Histological Parameters in ANCA-Associated Vasculitis 58
Bowman's capsule rupture on renal biopsy improves the outcome prediction of ANCA-associated glomerulonephritis classifications 55
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 54
Spatial transcriptome of a germinal center plasmablastic burst hints at MYD88/CD79B mutants-enriched diffuse large B-cell lymphomas 49
The evolving landscape of anatomic pathology 48
An Indeterminate for Malignancy FNA Report Does Not Increase the Surgical Risk of Incidental Thyroid Carcinoma 47
Use of diagnostic criteria from acr and eu-tirads systems to improve the performance of cytology in thyroid nodule triage 45
Pathologist Validation of a Machine Learning-Derived Feature for Colon Cancer Risk Stratification 44
Digital pathology for the routine diagnosis of renal diseases: a standard model 44
Real-world digital pathology: considerations and ruminations of four young pathologists 44
Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity 43
Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis 42
MALDI-MS imaging in the search for proteomic indicators of response to therapy in membranous nephropathy 42
The Complex Cyto-Molecular Landscape of Thyroid Nodules in Pediatrics 39
The slow-paced digital evolution of pathology: lights and shadows from a multifaceted board 39
Goodpasture syndrome and anti-glomerular basement membrane disease 39
[IgG4-related kidney disease: what the nephrologist needs to know] 38
Renal diseases related to MYH9 disorders 37
Un nuovo approccio basato sull’Imaging con Spettrometria di Massa per la sottotipizzazione dell’amiloidosi renale [A novel mass spectrometry imaging based approach for the subtyping of renal amyloidosisn] 36
Cost analysis of archives in the pathology laboratories: from safety to management 34
Pre-Implantation Kidney Biopsies in Extended Criteria Donors: From On Call to Expert Pathologist, from Conventional Microscope to Digital Pathology 33
Monoclonal Gammopathy of Renal Significance: A Molecular Middle Earth between Oncology, Nephrology, and Pathology 32
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 32
Best practice recommendations for the implementation of a digital pathology workflow in the anatomic pathology laboratory by the european society of digital and integrative pathology (ESDIP) 30
The therapeutic potential of an allosteric non-competitive CXCR1/2 antagonist for diabetic nephropathy 29
Time for a full digital approach in nephropathology: a systematic review of current artificial intelligence applications and future directions 29
Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma 29
A survival guide for the rapid transition to a fully digital workflow: The “caltagirone example” 28
Clinical audit; freehand renal biopsy, still a suitable method? 27
Artificial intelligence-based tools applied to pathological diagnosis of microbiological diseases 27
Artificial intelligence–based algorithms for the diagnosis of prostate cancer: A systematic review 27
Renal involvement in eosinophilic granulomatosis with polyangiitis 26
What is essential is (no more) invisible to the eyes: The introduction of blocdoc in the digital pathology workflow 26
Unravelling the proteomic content and spatial distribution of amyloid causative proteins in renal biopsies using MALDI-MSI 24
The Puzzle of Preimplantation Kidney Biopsy Decision-Making Process: The Pathologist Perspective 19
Lymphoma and the Kidney: A Kidney Biopsy Teaching Case 19
Economic assessment of NGS testing workflow for NSCLC in a healthcare setting 18
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 18
Digital counting of tissue cells for molecular analysis: the QuANTUM pipeline 17
The Case | Acute kidney injury after liver and kidney transplantation 17
Differences between κ and λ light chain amyloidosis analyzed by a pathologic scoring system 16
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology 13
Benchmarking digital displays (monitors) for histological diagnoses: the nephropathology use case 12
Natural Language Processing to extract SNOMED-CT codes from pathological reports 11
Totale 9.132
Categoria #
all - tutte 35.614
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.614


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.115 134 55 80 97 81 147 166 83 103 71 68 30
2020/20211.704 76 66 123 152 159 170 166 198 148 159 120 167
2021/20221.186 145 130 127 68 68 101 26 79 32 83 123 204
2022/20231.923 183 503 192 146 106 274 53 144 163 41 81 37
2023/20241.944 67 84 86 121 188 441 349 70 175 40 87 236
2024/2025148 148 0 0 0 0 0 0 0 0 0 0 0
Totale 9.188